JS207 Clinical Trials
8 recruitingDrug
Phase 27Phase 12
Showing 1–8 of 8 trials
Recruiting
Phase 2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Breast CancerBreast NeoplasmHER2-negative Breast Cancer+7 more
Fudan University716 enrolled1 locationNCT05582499
Recruiting
Phase 2
Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy
Non-squamous Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.78 enrolled1 locationNCT06868836
Recruiting
Phase 2
JS212 Combination Therapies in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.80 enrolled1 locationNCT07503756
Recruiting
Phase 1Phase 2
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Solid Tumor
Mabwell (Shanghai) Bioscience Co., Ltd.280 enrolled1 locationNCT07466160
Recruiting
Phase 2
JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.84 enrolled1 locationNCT06969027
Recruiting
Phase 2
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd.72 enrolled12 locationsNCT06954467
Recruiting
Phase 2
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Advanced Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.60 enrolled2 locationsNCT06885385
Recruiting
Phase 1
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.93 enrolled1 locationNCT06571422